Andrea James - Feb 7, 2025 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
Chief Financial Officer
Signature
/s/ Andrea James
Stock symbol
OCX
Transactions as of
Feb 7, 2025
Transactions value $
$200,000
Form type
4
Date filed
2/11/2025, 07:00 PM
Previous filing
Dec 9, 2024
Next filing
Mar 28, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Purchase $200K +97.6K +181.78% $2.05 151K Feb 7, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a private placement pursuant to that certain Securities Purchase Agreement, dated as of February 7, 2025, by and among the Issuer and the investors signatory thereto.